Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming

Abstract

<jats:title>Abstract</jats:title> <jats:sec> <jats:title /> <jats:p>Unconventional T-lymphocyte populations are emerging as important regulators of tumor immunity. Despite this, the role of TCRαβ+CD4−CD8−NK1.1− innate αβ T cells (iαβT) in pancreatic ductal adenocarcinoma (PDA) has not been explored. We found that iαβTs represent ∼10% of T lymphocytes infiltrating PDA in mice and humans. Intratumoral iαβTs express a distinct T-cell receptor repertoire and profoundly immunogenic phenotype compared with their peripheral counterparts and conventional lymphocytes. iαβTs comprised ∼75% of the total intratumoral IL17+ cells. Moreover, iαβT-cell adoptive transfer is protective in both murine models of PDA and human organotypic systems. We show that iαβT cells induce a CCR5-dependent immunogenic macrophage reprogramming, thereby enabling marked CD4+ and CD8+ T-cell expansion/activation and tumor protection. Collectively, iαβTs govern fundamental intratumoral cross-talk between innate and adaptive immune populations and are attractive therapeutic targets.</jats:p> </jats:sec> <jats:sec> <jats:title>Significance:</jats:title> <jats:p>We found that iαβTs are a profoundly activated T-cell subset in PDA that slow tumor growth in murine and human models of disease. iαβTs induce a CCR5-dependent immunogenic tumor-associated macrophage program, T-cell activation and expansion, and should be considered as novel targets for immunotherapy.</jats:p> <jats:p>See related commentary by Banerjee et al., p. 1164.</jats:p> <jats:p>This article is highlighted in the In This Issue feature, p. 1143</jats:p> </jats:sec>

Department

Description

Provenance

Subjects

Citation

Published Version (Please cite this version)

10.1158/2159-8290.cd-19-0161

Publication Info

Hundeyin, Mautin, Emma Kurz, Ankita Mishra, Juan Andres Kochen Rossi, Shannon M Liudahl, Kenna R Leis, Harshita Mehrotra, Mirhee Kim, et al. (2019). Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming. Cancer Discovery, 9(9). pp. 1288–1305. 10.1158/2159-8290.cd-19-0161 Retrieved from https://hdl.handle.net/10161/30178.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Aykut

Berk Aykut

House Staff

College/University: Ruprecht Karl University of Heidelberg

Medical School: Ruprecht Karl University of Heidelberg


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.